Dashboard
Manage Tickers

SUPN


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

supernus-pharmaceuticals-announces-interim-analysis-data-from-phase-2a-clinical-study-of-spn-817-for-treatment-resistant-seizures
Supernus Pharmaceuticals Announces Interim...
05/23/2024 20:09:21

supernus-pharmaceuticals-reiterates-fy24-revenue-580m-620m-vs-601461m-est
Supernus Pharmaceuticals Reiterates FY24 R...
05/08/2024 21:25:29

supernus-pharmaceuticals-q1-sales-143600m-miss-145832m-estimate
Supernus Pharmaceuticals Q1 Sales $143.600...
05/08/2024 21:21:47

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly sales of $143.600 million which missed the analyst consensus estimate...

m8-pharmaceuticals-signs-an-exclusive-licensing-agreement-with-supernus-pharmaceuticals-to-seek-regulatory-approval-and-commercialize-qelbree-under-m8s-trademark-in-latin-america
M8 Pharmaceuticals Signs An Exclusive Lice...
05/07/2024 14:03:00

M8 Pharmaceuticals, an Acino company ('M8') announces that the company has signed an exclusive licensing agreement with...

supernus-pharmaceuticals-faces-second-fda-rejection-for-investigational-device-for-parkinsons-disease
Supernus Pharmaceuticals Faces Second FDA ...
04/08/2024 14:11:37

Supernus Pharmaceuticals receives FDA Complete Response Letter for SPN-830, an investigational apomorphine infusion device for ...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
04/08/2024 12:09:45

supernus-provides-regulatory-update-for-spn-830-fda-has-issued-a-crl-in-response-to-the-cos-nda-for-spn-830-indicating-that-the-review-cycle-for-the-application-is-complete-but-that-the-application-is-not-ready-for-approval-in-its-present-form
Supernus Provides Regulatory Update For SP...
04/08/2024 12:06:03

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products fo...

piper-sandler-maintains-overweight-on-supernus-pharmaceuticals-lowers-price-target-to-41
Piper Sandler Maintains Overweight on Supe...
02/28/2024 15:40:29

Piper Sandler analyst David Amsellem maintains Supernus Pharmaceuticals (NASDAQ:SUPN) with a Overweight and lowers the price...

supernus-sees-fy24-total-revenue-580m-620m-vs-62252m-est
Supernus Sees FY24 Total Revenue $580M-$62...
02/27/2024 22:15:26

recap-supernus-pharmaceuticals-q4-earnings
Recap: Supernus Pharmaceuticals Q4 Earnings
02/27/2024 21:30:12

supernus-pharmaceuticals-q4-2023-adj-eps-039-misses-055-estimate-sales-16431m-beat-15503m-estimate
Supernus Pharmaceuticals Q4 2023 Adj EPS $...
02/27/2024 21:30:06

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly earnings of $0.39 per share which missed the analyst consensus estima...

earnings-scheduled-for-february-27-2024
Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

supernus-pharmaceuticals-wins-infringement-and-validity-case-on-trokendi-xr
Supernus Pharmaceuticals Wins Infringement...
02/05/2024 13:36:59

United States District Court for the District of New Jersey ruled that Torrent Pharmaceuticals Ltd. and its subsidiary, Torrent...

supernus-pharmaceuticals-has-granted-rights-to-knight-therapeutic-to-seek-regulatory-approval-and-commercialize-qelbree-in-canada-for-attention-deficit-hyperactivity-disorder-financial-terms-of-the-agreement-were-not-disclosed
Supernus Pharmaceuticals Has Granted Right...
12/19/2023 12:40:43

botox-and-similar-injections-have-associated-risks-consumer-group-pushes-for-stronger-warnings
Botox And Similar Injections Have Associat...
12/12/2023 19:04:27

Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regardi...

piper-sandler-maintains-overweight-on-supernus-pharmaceuticals-raises-price-target-to-43
Piper Sandler Maintains Overweight on Supe...
11/09/2023 19:56:59

Piper Sandler analyst David Amsellem maintains Supernus Pharmaceuticals (NASDAQ:SUPN) with a Overweight and raises the price...

supernus-pharmaceuticals-narrows-fy23-revenue-from-580m-620m-to-590-610-vs-59428m-est
Supernus Pharmaceuticals Narrows FY23 Reve...
11/08/2023 21:56:16

supernus-pharmaceuticals-q3-earnings-insights
Supernus Pharmaceuticals: Q3 Earnings Insi...
11/08/2023 21:30:15

supernus-pharmaceuticals-q3-2023-eps-029-down-from-003-yoy-revenue-1539m-beats-143387m-estimate
Supernus Pharmaceuticals Q3 2023 EPS $(0.2...
11/08/2023 21:26:04

earnings-scheduled-for-november-8-2023
Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)